Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
On June 24, 2026, Novo Nordisk, a global leader in diabetes and obesity treatments, officially launched its flagship weight-loss drug Wegovy (Semaglutide) in India
WARNHINWEISE Auerhalb der Reichweite von Kindern aufbewahren
Risks may also increase for individuals with preexisting lipid disorders, hypertension, or impaired pancreatic function
A., Jeffery, R
Going to ask if I can have a blood test to look at other possible deficiencies and to look at thyroid function etc
It is the first FDA- approved drug since 2017 for chronic weight management in overweight adults with obesity
US$ 29.11
US$ 21.25
US$ 20.72
US$ 28.10
US$ 23.70
US$ 28.61
US$ 20.68
